Disruption of the cytoskeleton after apoptosis induction with autoantibodies

Ingrid Böhm1

  • 1Department of Radiology, University of Bonn, Sigmund-Freud Strasse 25, 53105 Bonn, Germany. i.boehm@uni-bonn.de

Autoimmunity
|August 13, 2003
PubMed

Insights

Anti-double-stranded DNA (dsDNA) antibodies induce F-actin disruption and caspase 3 activation in peripheral blood mononuclear cells (PBMC). This leads to less phosphatidylserine (PS) externalization, potentially reducing apoptotic cell clearance and promoting autoantibody production.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Autoimmune diseases are often characterized by the presence of autoantibodies.
  • Anti-double-stranded DNA (anti-dsDNA) antibodies are key autoantibodies in systemic lupus erythematosus (SLE).
  • Apoptosis, or programmed cell death, plays a crucial role in maintaining tissue homeostasis and preventing autoimmunity.

Purpose of the Study:

  • To investigate the effects of anti-dsDNA antibodies on F-actin disruption and phosphatidylserine (PS) externalization during apoptosis in peripheral blood mononuclear cells (PBMC).
  • To explore the relationship between F-actin disruption, caspase 3 activation, and PS externalization in anti-dsDNA antibody-treated cells.
  • To understand the implications of these cellular changes for the clearance of apoptotic cells and subsequent autoantibody production.

Main Methods:

  • Peripheral blood mononuclear cells (PBMC) were treated with anti-dsDNA antibodies.
  • F-actin disruption was assessed by FITC-phalloidin staining.
  • Phosphatidylserine (PS) externalization was detected by annexin V binding.
  • Caspase 3 activation was measured within the cytoplasm.

Main Results:

  • Anti-dsDNA antibody treatment significantly induced F-actin disruption in PBMC (p < 0.006).
  • Despite similar F-actin disruption, PS externalization was significantly lower in cells treated with anti-dsDNA antibodies compared to untreated cells (58.4% vs. 81.9%).
  • F-actin disruption correlated strongly with caspase 3 activation (r = -0.92599; p < 8.87 x 10^-10) in both treated and untreated cells.

Conclusions:

  • Anti-dsDNA antibody-induced apoptosis is characterized by more pronounced intracellular changes (F-actin disruption, caspase 3 activation) than cell surface alterations (PS externalization).
  • The diminished PS externalization may lead to reduced phagocytosis of apoptotic cells.
  • Impaired clearance of apoptotic cells could contribute to the perpetuation of autoimmunity by promoting autoantibody production against cellular epitopes exposed during apoptosis.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...